Severe hypoglycemia following venlafaxine intoxication: a case report.
Meertens
John H J M
JH
Monteban-Kooistra
Wilma E
WE
Ligtenberg
Jack J M
JJ
Tulleken
Jaap E
JE
Zijlstra
Jan G
JG
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000506:poisoning*; D000931:Antidotes / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002606:Charcoal / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D003422:Critical Care; D003511:Cyclohexanols / Q000506:poisoning*; D003866:Depressive Disorder / Q000150:complications / Q000523:psychology; D015600:Glasgow Coma Scale; D006801:Humans; D006993:Hypnotics and Sedatives / Q000506:poisoning; D007003:Hypoglycemia / Q000139:chemically induced*; D008297:Male; D010076:Oxazepam / Q000506:poisoning; D012121:Respiration, Artificial; D013313:Stress Disorders, Post-Traumatic / Q000150:complications / Q000523:psychology; D013406:Suicide, Attempted; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000931:Antidotes; D001786:Blood Glucose; D003511:Cyclohexanols; D006993:Hypnotics and Sedatives; D002606:Charcoal; D010076:Oxazepam; D000069470:Venlafaxine Hydrochloride; D003402:Creatine Kinase